138 results
Page 3 of 7
8-K
EX-99.1
3ksn164202hwb jl
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
476pp14g
10 Aug 22
Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase
12:00am
8-K
EX-99.1
t397 vthqw
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
DEF 14A
0z4pr c8fq64iff7
22 Jun 22
Definitive proxy
4:22pm
PRE 14A
mrif4
10 Jun 22
Preliminary proxy
4:25pm
8-K
EX-99.1
s6jwsts5
10 Jun 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
lvf26g80 8u44j
2 Jun 22
Gamida Cell Completes
7:31am
POS AM
6bwdt6vz1lsmic2t
1 Jun 22
Prospectus update (post-effective amendment)
4:56pm
10-Q
link5fa2
12 May 22
Quarterly report
7:42am
8-K
EX-99.1
rxtq5li
10 May 22
Gamida Cell Reports First Quarter 2022 Financial Results
7:30am
8-K
EX-99.1
8p8ko
26 Apr 22
Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201
7:30am
POS AM
p8ia 6z08
25 Mar 22
Prospectus update (post-effective amendment)
4:31pm
10-K
EX-3.1
apam4xronrdd2
24 Mar 22
Annual report
7:30am
10-K
54bzvlqz9m4u7o5k5gt2
24 Mar 22
Annual report
7:30am
10-K
EX-10.1
edb8ocos j53e0a
24 Mar 22
Annual report
7:30am
8-K
EX-99.1
myewdva28eyhups67ymb
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am
8-K
EX-99.1
nob6w 6mqkjblgq
9 Feb 22
On track to complete the BLA submission in the first half of 2022
7:30am
8-K
EX-99.1
jfhosf45 0b
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
8-K
EX-99.1
mqmare 90ph2ghw
19 Jan 22
Gamida Cell Provides Update on Omidubicel BLA Submission
7:00am